Biotest
Dr. Carolin Vitten is a seasoned clinical operations professional with extensive experience in clinical trial management and informed consent processes. Currently serving as Clinical Operations Manager and Manager of Corporate Medical Affairs at Biotest AG since September 2022, Dr. Vitten previously held key positions at Merck KGaA, where roles included Associate Director and Informed Consent Specialist, focusing on improving ICF processes in global Phase I-IV studies. Prior experiences include Site Activation Manager for Eli Lilly, Study Start-up Manager, and Clinical Trial Manager at ICON plc, demonstrating a strong background in team management, regulatory compliance, and process optimization within various clinical settings. Dr. Vitten holds a Ph.D. in Neuroscience from Johannes Gutenberg University Mainz and has a solid foundation in education with a degree in Biology and French.
This person is not in any offices
Biotest
Biotest AG is a Germany-based provider of plasma proteins and biological drugs. The Company, with a chain that extends from pre-clinical and clinical development to worldwide marketing and distribution, mainly specializes in the areas of clinical immunology, hematology and intensive care medicine. Biotest AG develops, manufactures and markets immunoglobulin, coagulation factors and albumins based on human blood plasma. These are used for diseases of the immune and hematopoietic systems. In addition, the Company develops monoclonal antibodies in the indications of cancer of plasma cells and systemic lupus erythematosus, which are produced by recombinant technologies.